Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_provenance.
- NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_assertion description "[Although corticotropin-releasing hormone (CRH) and Fas ligand (FasL) have been documented in ovarian carcinoma, a clear association with tumour progression and immuno-escape has not been established.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_provenance.
- NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_assertion evidence source_evidence_literature NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_provenance.
- NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_assertion SIO_000772 17667919 NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_provenance.
- NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_assertion wasDerivedFrom befree-20150227 NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_provenance.
- NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_assertion wasGeneratedBy ECO_0000203 NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP326118.RAQFhqFZiFqG1_O5Ob9MyWcxxXfy1UW0h62cT3g7ER3WE130_provenance.